tirzepatide shortage resolved π¨ Alert: No Longer on FDA's Drug List As of October 2, 2024, the FDA has announced that the Tirzepatide shortage has been resolved. This means that all doses of Breaking News: OFA Challenges FDA
Description
This dual action is crucial to its success, allowing the medication to leverage the benefits of both hormones for improved outcomes
Update on the obesity epidemic: after the sudden rise, is the upward trajectory beginning to flatten
Oral formulations typically have broader temperature stability than injectable forms, though you should still avoid extreme heat
Lets break down what the research shows, how alcohol may affect your body differently on Zepbound, and what to keep in mind if you choose to drink
9 and Supplementary Tables 8, 9)
